Innoviva (INVA) Operating Margin (2011 - 2026)
Innoviva posted quarterly Operating Margin of 38.94% for Q1 2026, down 781.0% year-on-year from 5.72% in Q1 2025, and up 103.06% on a QoQ basis from 1274.01% in Q4 2025.
Innoviva (INVA) has 16 years of Operating Margin data on file, last reported at 38.94% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 781.0% year-over-year to 38.94%; the trailing twelve-month figure through Mar 2026 stood at 35.05% (down 1107.0% YoY), and the FY2025 full-year result was 39.81%, down 671.0% from the prior year.
- Operating Margin for Q1 2026 stood at 38.94%, up from 1274.01% in the prior quarter.
- Across five years, Operating Margin topped out at 127.79% in Q3 2023 and bottomed at 1425.38% in Q1 2023.
- The 5-year median for Operating Margin is 430.5% (2023), against an average of 459.37%.
- The widest annual swing landed in 2022, when Operating Margin slumped 875506 bps; it then surged 110554 bps in 2025.
- A 5-year view of Operating Margin shows it stood at 982.68% in 2022, then soared by 56 bps to 430.5% in 2023, then sank by 98 bps to 853.36% in 2024, then plunged by 49 bps to 1274.01% in 2025, then jumped by 103 bps to 38.94% in 2026.
- The last three Operating Margin figures came in at 38.94% (Q1 2026), 1274.01% (Q4 2025), and 32.08% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 38.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.94% |
| Dec 31, 2025 | -1,274.01% |
| Sep 30, 2025 | 32.08% |
| Jun 30, 2025 | 48.61% |
| Mar 31, 2025 | 46.74% |
| Dec 31, 2024 | -853.36% |
| Sep 30, 2024 | 48.31% |
| Jun 30, 2024 | 54.74% |
| Mar 31, 2024 | -1,058.80% |
| Dec 31, 2023 | -430.50% |
| Sep 30, 2023 | 127.79% |
| Jun 30, 2023 | -982.55% |
| Mar 31, 2023 | -1,425.38% |
| Dec 31, 2022 | -982.68% |
| Sep 30, 2022 | 0.38% |
| Jun 30, 2022 | -489.64% |
| Mar 31, 2022 | -709.95% |
| Dec 31, 2021 | -611.53% |
| Sep 30, 2021 | 96.62% |
| Jun 30, 2021 | 8,265.41% |
| Mar 31, 2021 | -509.85% |
| Dec 31, 2020 | -1,280.36% |
| Sep 30, 2020 | 95.19% |
| Jun 30, 2020 | 96.00% |
| Mar 31, 2020 | 96.74% |
| Dec 31, 2019 | 96.93% |
| Sep 30, 2019 | 92.45% |
| Jun 30, 2019 | 93.22% |
| Mar 31, 2019 | 94.54% |
| Dec 31, 2018 | 96.70% |
| Sep 30, 2018 | 93.48% |
| Jun 30, 2018 | 93.42% |
| Mar 31, 2018 | 77.69% |
| Dec 31, 2017 | 95.53% |
| Sep 30, 2017 | 82.28% |
| Jun 30, 2017 | 81.67% |
| Mar 31, 2017 | 72.47% |
| Dec 31, 2016 | 86.35% |
| Sep 30, 2016 | 83.82% |
| Jun 30, 2016 | 79.69% |
| Mar 31, 2016 | 72.52% |
| Dec 31, 2015 | 75.73% |
| Sep 30, 2015 | 62.19% |
| Jun 30, 2015 | 47.94% |
| Mar 31, 2015 | 10.80% |
| Dec 31, 2014 | 1.79% |
| Sep 30, 2014 | -955.16% |
| Jun 30, 2014 | -1,048.61% |
| Mar 31, 2014 | -1,887.56% |
| Dec 31, 2013 | -503.53% |
| Sep 30, 2013 | -1,857.11% |
| Jun 30, 2013 | -521.79% |
| Mar 31, 2013 | -2,525.49% |
| Dec 31, 2012 | 33.88% |
| Sep 30, 2012 | -2,332.17% |
| Jun 30, 2012 | -6,827.72% |
| Mar 31, 2012 | 68.39% |
| Dec 31, 2011 | -663.47% |
| Sep 30, 2011 | -454.08% |
| Jun 30, 2011 | -370.28% |
| Mar 31, 2011 | -336.47% |